FDA Inspection
New York Blood Center EnterprisesNew York Blood Center Enterprises – FDA Inspection, Apr 23, 2026
Record Details
This FDA Inspection record concerns New York Blood Center Enterprises, with an inspection on April 23, 2026, issued by the New York District Office, covering biologics.
View Company Profile
ID · 4dba5893-4e1a-4c8e-bb21-4208e3e34b7a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1313734
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New York Blood Center Enterprises
7| Date | Classification | Office | Project area |
|---|---|---|---|
| December 22, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 6, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 4, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 4, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 24, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Blood Center Enterprises
- FDA Inspection 1226373 - 2023-12-22
- FDA Inspection 1110447 - 2019-11-06
- FDA Inspection 1012914 - 2017-05-04
- FDA Inspection 940732 - 2015-09-04
- FDA Inspection 852575 - 2013-10-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.